Ocular Finding in Alopecia Areata
NCT03155958 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2017-05-16
Summary
Alopecia areata (AA) is a common, idiopathic and sometimes recurrent non-scarring type of hair loss.
Several etiological factors, including psychological, trauma-related, genetic and autoimmune factors have been considered as possible etiological factors . A T cell-mediated autoimmune mechanism in genetically vulnerable individuals is the most acceptable etiology.
Alopecia areata presents clinically with well demarcated patches of non cicatricial hair loss in any hair bearing area with no remarkable gender preference.
Although AA may occur at any age, incidence is high among younger age groups. In fact, it is the most common form of alopecia seen in children. Various clinical patterns of alopecia have been described as patchy, diffuse, reticulate, ophiasis and ophiasis inversus. Depending on the extent of hair loss, it can be classified into alopecia subtotalis, alopecia totalis (complete loss of scalp hair), and alopecia universalis (complete loss of body hair).
National Alopecia Areata Foundation has devised "Severity of Alopecia Tool Score" (SALT score) as a measure of disease severity. Scalp is divided into 4 areas, namely, Vertex-40% of scalp surface area; right and left profiles-18% each and posterior scalp aspect-24%. SALT score is the sum of percentage of hair loss in the above mentioned areas.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2019-07-01
- Completion
- 2020-01-01
More Related Trials
-
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
NCT02684123 ·Status: COMPLETED ·Phase: NA
-
Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata
NCT01559584 ·Status: COMPLETED ·Phase: NA
-
Psychosocial Stress on QOL in Saudi Arabian Patients with Alopecia Areata
NCT06802705 ·Status: COMPLETED
-
Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma
NCT05954104 ·Status: COMPLETED ·Phase: NA
-
Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
NCT03473600 ·Status: UNKNOWN ·Phase: PHASE4
-
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
NCT06531109 ·Status: RECRUITING
-
Excimer Light and Topical Steroid in Treatment of Alopecia Areata
NCT04793945 ·Status: UNKNOWN ·Phase: PHASE4
-
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
NCT06399783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
New Treatment of Alopecia Areata
NCT05594316 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata
NCT05485571 ·Status: UNKNOWN ·Phase: NA
-
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
NCT05098600 ·Status: COMPLETED
-
Quality of Life Comparison in Patients With Different Types of Alopecia
NCT04246957 ·Status: COMPLETED
-
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
NCT04239521 ·Status: COMPLETED
-
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
NCT02018042 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata
NCT07023302 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
NCT01385839 ·Status: TERMINATED ·Phase: NA
-
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
NCT02684097 ·Status: COMPLETED ·Phase: PHASE2
-
The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
NCT00999869 ·Status: UNKNOWN ·Phase: NA
-
Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata
NCT05885269 ·Status: COMPLETED ·Phase: PHASE1
-
Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata
NCT05861401 ·Status: UNKNOWN ·Phase: NA
-
Healthcare Disparities in Alopecia Areata
NCT05727306 ·Status: COMPLETED
-
Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.
NCT05926882 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240 ·Status: RECRUITING ·Phase: PHASE3
-
Pharmacogenomic Study of Androgenetic Alopecia
NCT01227031 ·Status: UNKNOWN
-
Systemic Treatments for Alopecia Areata Registry
NCT06283316 ·Status: RECRUITING